FCPM III SERVICES B.V. — 13F Holdings & Portfolio

CIK 2013410 · latest 13F-HR filed 2026-08-14

FCPM III SERVICES B.V. manages $750.4M in 13F-reported U.S. long-equity assets across 15 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are NAMS (20.99%), NAMS (17.35%), MPLT (15.41%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position and exited 0; 2 existing positions rose in reported value and 3 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$750.4M

Long-equity book

Holdings
15

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+1 / −0 / ↑2 / ↓3

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 100%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Apr 14, 2026.

Address
GOOIMEER 2-35
NAARDEN 1411DC
Netherlands
Phone
+31 35 699 3000
Name Title / Status Ownership Type
FORBION GROUP HOLDING B.V. ControlMANAGING MEMBER
since Nov 2012
75% or moreForeign Entity
Groeneveld, Machteld, NMN ControlCHIEF LEGAL, RISK, & COMPLIANCE OFFICER
since Jan 2026
Less than 5%Individual
VAN OSCH, MARTIEN, ADRIANUS ControlCHIEF FINANCIAL OFFICER
since Jan 2026
Less than 5%Individual
Ownership & leadership changes · 2 filings with changes since Apr 4, 2012

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Feb 12, 2026 filing
  • No longer listedFCPM III SERVICES BV · SHAREHOLDERS · 75% or more · control person · listed since Nov 2012
  • AddedFORBION GROUP HOLDING B.V. · MANAGING MEMBER · 75% or more · control person
  • AddedGroeneveld, Machteld, NMN · CHIEF LEGAL, RISK, & COMPLIANCE OFFICER · Less than 5% · control person
  • AddedVAN OSCH, MARTIEN, ADRIANUS · CHIEF FINANCIAL OFFICER · Less than 5% · control person
Mar 24, 2021 filing
  • No longer listedFORBION CAPITAL PARTNERS MANAGEMENT SERVICES BV · SHAREHOLDERS · 75% or more · control person · listed since Nov 2006
  • AddedFCPM III SERVICES BV · SHAREHOLDERS · 75% or more · control person
Apr 4, 2012 filing (earliest on record)
  • ListedFORBION CAPITAL PARTNERS MANAGEMENT SERVICES BV · SHAREHOLDERS · 75% or more · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 2 →

Top Trims

Show all 3 →

New Positions

Show all 1 →

Exited Positions

  • No exits this quarter.
Show all 0 →

FCPM III SERVICES B.V. Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 NEWAMSTERDAM PHARMA COMPANY NAMS N62509109 $157.5M 20.99% 4,648,025 SH
2 NEWAMSTERDAM PHARMA COMPANY NAMS N62509109 $130.2M 17.35% 3,842,328 SH
3 MAPLIGHT THERAPEUTICS INC MPLT 56565P103 $115.6M 15.41% 3,226,400 SH
4 VOR BIOPHARMA INC VOR 929033207 $75.8M 10.10% 4,117,354 SH
5 DAMORA THERAPEUTICS INC DMRA 36322Q206 $63.5M 8.46% 2,441,000 SH
6 DYNE THERAPEUTICS INC DYN 26818M108 $53.8M 7.17% 2,421,886 SH
7 DYNE THERAPEUTICS INC DYN 26818M108 $31.7M 4.22% 1,426,370 SH
8 REPLIMUNE GROUP INC REPL 76029N106 $31.1M 4.14% 2,808,368 SH
9 CRESCENT BIOPHARMA INC. CBIO G2545C104 $30.2M 4.02% 1,677,852 SH
10 AURA BIOSCIENCES INC AURA 05153U107 $28.8M 3.84% 4,053,775 SH
11 BICYCLE THERAPEUTICS PLC BCYC 088786108 $14.7M 1.96% 3,468,430 SH
12 ENGENE HOLDINGS INC ENGNW 29286M105 $11.7M 1.55% 6,738,362 SH
13 ENGENE HOLDINGS INC ENGNW 29286M105 $5.0M 0.67% 2,894,199 SH
14 ENGENE HOLDINGS INC ENGNW 29286M113 $696.7K 0.09% 2,403,072 SH
15 ENGENE HOLDINGS INC ENGNW 29286M113 $137.7K 0.02% 475,076 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $750.4M 15 0001193125-26-350207
2026-03-31 2026-05-15 $722.2M 14 0001193125-26-225423
2025-12-31 2026-02-17 $762.9M 14 0001193125-26-053151
2025-09-30 2025-11-14 $500.4M 13 0001193125-25-281853
Filer Information
Address
GOOIMEER 2-35
NAARDEN, P7 1411 DC
Phone
31356993000
Filing Manager
FCPM III SERVICES B.V.
NAARDEN, P7
Signatory
M.A. van Osch and G.J. Mulder
Directors